SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists
SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists
SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
F9 <br />
ESTIMA TE OF DETECTION PERIOD IN URINE FOR MARKERS OF STREET HEROIN<br />
Sue Paterson*, Rosa Cordero, Simon Burlinson<br />
Toxicology Unit, Imperial College London, St Dunstan's Road, London W6 8RP, UK<br />
Nick Lintzeris<br />
National Addiction Centre, 4 Windsor Walk, London SE5, UK<br />
There is growing international interest in prescribed pharmaceutical heroin as treatment for individuals who<br />
are unable to stop injecting opiate drugs. The rationale for this treatment is one <strong>of</strong> "harm minimisation". In<br />
a previous paper (1) co-workers reported on the GC-MS analysis <strong>of</strong> over 1000 urine samples from patients<br />
attending a substance misuse service during which metabolites <strong>of</strong> various contaminants <strong>of</strong> street heroin<br />
were detected. They concluded that the detection <strong>of</strong> papaverine and noscapine metabolites was likely to<br />
provide a reasonably sensitive and highly specific means <strong>of</strong> identifying the illicit use <strong>of</strong> heroin in patients<br />
prescribed diamorphine. We believe that these markers <strong>of</strong>fer the best means <strong>of</strong> determining the use <strong>of</strong> street<br />
heroin in these patients. The aim <strong>of</strong> this study was to estimate the detection period for identifying markers<br />
in the urine <strong>of</strong> street heroin users. Over 50 urine samples were collected from patients who admitted to the<br />
use <strong>of</strong> street heroin within the previous 72 hours. The researcher interviewed each subject regarding all<br />
episodes <strong>of</strong> drug use within the preceding 72 hours, including details <strong>of</strong> amount used, route <strong>of</strong><br />
administration and time <strong>of</strong> use. The time the urine was passed was also noted. These samples were analysed<br />
by the method currently in use for the routine analysis <strong>of</strong> urine samples from patients attending drug<br />
treatment centres, that is mixed-mode solid-phase extraction (SPE) followed by GC-MS (2). Urine samples<br />
were subjected to enzymatic hydrolysis followed by SPE using Bakerbond narc-2 columns. The eluent was<br />
selectively derivatised with N-methyl-bis-tritluoroacetamide and N-methyl-N-trimethylsilyltrifluoroacetamide<br />
+ 1% trimethylchlorosilane. Analysis was performed using a GC-MS system operating in full<br />
scan mode. The study samples were analysed for the commonly abused drugs plus a range <strong>of</strong> other drugs<br />
including antidepressants and certain anti psychotics that are prescribed to these patients. In addition, the<br />
metabolites <strong>of</strong> papaverine, hydroxy and dihydroxypapaverine, and the metabolites <strong>of</strong> noscapine, meconine<br />
and hydroxymeconine, were looked for in each sample. Other contaminants <strong>of</strong> street heroin including<br />
papaverine, noscapine, thebaine, and acetylcodeine were also monitored. Using this assay the limit <strong>of</strong><br />
detection for morphine was 0.05 ugimL. The limit <strong>of</strong> detection for hydroxy and dihydroxypapaverine could<br />
not be determined as pure standards were not commercially available. A characteristic peak pattern in the<br />
chromatogram was found to be indicative <strong>of</strong> the presence <strong>of</strong> the papaverine metabolites, which were then<br />
matched by retention time and spectra obtained from the elucidation <strong>of</strong> these metabolite derivatives as<br />
reported previously (1). Initial analysis <strong>of</strong> the data shows that hydroxy and dihydroxpapaverine were<br />
detected in urine for approximately the same period as morphine. This data supports the findings <strong>of</strong><br />
McLachlan-Troup et al that hydroxy and dihydroxypapaverine can be used to determine if patients<br />
prescribed injectable diamorphine are "topping-up" with street heroin. Papaverine, noscapine, thebaine and<br />
acetyl codeine were not detected in any <strong>of</strong> the study samples.<br />
l. N, McLachlan-Troup, G.W. Taylor, B.c. Trathen. Diamorphine treatment for opiate dependence:<br />
putative markers <strong>of</strong> concomitant heroin misuse. Addiction Biology, 2001; 6: 223-231<br />
2. S Paterson, R Cordero, S McCulloch, P Houldsworth. Analysis <strong>of</strong> urine for drugs <strong>of</strong> abuse using mixedmode<br />
solid-phase extraction and gas chromatography/mass spectrometry. Ann. Ojefin. Biochem. 2000; 37:<br />
690-700.<br />
Keywords: Street heroin markers, papaverine metabolites, noscapine metabolites<br />
Page 262